Form 4 Filing for Anika Therapeutics, Inc.

Joseph H. Capper, a director at Anika Therapeutics, Inc., acquired 10,402 shares of Common Stock on June 18, 2026. The acquisition was made at a price of $0.0 per share, with the shares representing restricted stock units (RSUs). These RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027. Following this transaction, Capper holds a total of 30,805 shares. The transaction code was 'A' for acquisition, and the ownership is direct.